Cardiometabolic factors and disease duration in patients with Parkinson's disease

Nutrition

Volumn 29, Issue 11-12, 2013, Pages 1331-1335

  Cassani, Erica ^a   Cereda, Emanuele ^b   Barichella, Michela ^a   Madio, Carmen ^a   Cancello, Raffaella ^a   Caccialanza, Riccardo ^b   Zini, Michela ^a   Cilia, Roberto ^a   Pezzoli, Gianni ^a  

^a PARKINSON INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Adiposity; Cardiometabolic risk factors; Disease duration; Nutritional status; Parkinson's disease

Indexed keywords

AMANTADINE; AMINOTRANSFERASE; APOMORPHINE; BIPERIDEN; ENTACAPONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; SELEGILINE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEX DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSITY; CARDIOMETABOLIC RISK FACTORS; DISEASE DURATION; NUTRITIONAL STATUS; PARKINSON'S DISEASE;

ADIPOSE TISSUE; ADIPOSITY; AGED; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEVODOPA; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PARKINSON DISEASE; RISK FACTORS; TIME FACTORS; TRANSAMINASES; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84884986332     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.04.013     Document Type: Article

References (23)

1. Barichella M., Marczewska A., Vairo A., Canesi M., Pezzoli G. Is underweightness still a major problem in Parkinson's disease patients?. Eur J Clin Nutr 2003, 57:543-547.
2. Cereda E., Cassani E., Barichella M., Caccialanza R., Pezzoli G. Anthropometric indices of fat distribution and cardiometabolic risk in Parkinson's disease. Nutr Metab Cardiovasc Dis 2013, 23:264-271.
3. Fall P.A., Saleh A., Fredrickson M., Olsson J.E., Granérus A.K. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord 2003, 18:1312-1316.
4. Beyer M.K., Herlofson K., Arsland D., Larsen J.P. Causes of death in a community based study of Parkinson's disease. Acta Neurol Scand 2001, 103:7-11.
5. Cereda E., Cassani E., Barichella M., Spadafranca A., Caccialanza R., Bertoli A., et al. Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 2012, 31:699-704.
6. Scigliano G., Musicco M., Soliveri P., Piccolo I., Ronchetti G., Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 2006, 37:1184-1188.
7. Scigliano G., Ronchetti G., Girotti F., Musicco M. Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease. Parkinsonism Relat Disord 2009, 15:138-143.
8. Barichella M., Cereda E., Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009, 24:1881-1892.
9. Lee J.M., Park K.W., Seo W.K., Park M.H., Han C., Jo I., et al. Carotid intima-media thickness in Parkinson's disease. Mov Disord 2007, 22:2446-2449.
10. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improves the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001, 57(Suppl 3):S34e8.
11. Hoehn M., Yahr M. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
12. Fahn S., Elton R.L. UPDRS Program Members. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, Vol. 2:153-163. Macmillan Healthcare Information, Florham Park, NJ, 293-304. S. Fahn, C.D. Marsden, M. Goldstein, D.B. Calne (Eds.).
13. Cereda E., Bertoli S., Battezzati A. Height prediction formula for middle-aged (30e55y) Caucasians. Nutrition 2010, 26:75-81.
14. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. World Health Organ Tech Rep Ser 1995, 854:1-452. World Health Organization.
15. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gomez J.M., et al. Composition of the ESPEN working group. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr 2004, 23:1226e43.
16. Huxley R., Mendis S., Zheleznyakov E., Reddy S., Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature. Eur J Clin Nutr 2010, 64:16-22.
17. Ritchie S.A., Connell J.M.C. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007, 17:319-326.
18. Adams F., Boschmann M., Lobsien E., Kupsch A., Lipp A., Franke G., et al. Influences of levodopa on adipose tissue and scheletal muscle metabolism in patients with idiopathic Parkinson's disease. Eur J Clin Pharmacol 2008, 64:863-870.
19. Durstine J.L., Grandjean P.W., Davis P.G., Ferguson M.A., Alderson N.L., DuBose K.D. Blood lipid and lipoprotein adaptations to exercise:a quantitative analysis. Sports Med 2001, 31:1033-1062.
20. Rieu I., Pereira B., Derost P., Ulla M., Marques A., Lemaire J.J., et al. Does deep brain stimulation of the subthalamic nucleus induce metabolic syndrome in Parkinson's disease?. E Spen Eur E J Clin Nutr Metab 2011, 6:e126-e130.
21. Kuranuki S., Arai C., Terada S., Aoyama T., Nakamura T. Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease. Nutrition 2011, 27:239-243.
22. Cereda E., Barichella M., Pedrolli C., Pezzoli G. Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: a systematic review. Mov Disord 2010, 25:2021-2034.
23. Marczewska A., De Notaris R., Sieri S., Barichella M., Fusconi E., Pezzoli G. Protein intake in Parkinsonian patients using the EPIC food frequency questionnaire. Mov Disord 2006, 21:1229-1231.